Ocuphire Pharma Stock Price on November 25, 2020
| OCUP Stock | USD 1.53 0.01 0.65% |
Below is the normalized historical share price chart for Ocuphire Pharma extending back to November 30, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ocuphire Pharma stands at 1.53, as last reported on the 25th of April, with the highest price reaching 1.56 and the lowest price hitting 1.50 during the day.
If you're considering investing in Ocuphire Stock, it is important to understand the factors that can impact its price. Ocuphire Pharma maintains Sharpe Ratio (i.e., Efficiency) of -0.2, which implies the firm had a -0.2% return per unit of risk over the last 3 months. Ocuphire Pharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Ocuphire Pharma's Variance of 16.19, risk adjusted performance of (0.11), and Coefficient Of Variation of (515.03) to confirm the risk estimate we provide.
At this time, Ocuphire Pharma's Total Stockholder Equity is relatively stable compared to the past year. As of 04/25/2024, Liabilities And Stockholders Equity is likely to grow to about 56.6 M, while Common Stock is likely to drop 1,710. . As of 04/25/2024, Price Earnings To Growth Ratio is likely to grow to 0.05, while Price To Sales Ratio is likely to drop 3.24. Ocuphire Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of May 2005 | 200 Day MA 3.0422 | 50 Day MA 2.1326 | Beta 0.242 |
Ocuphire |
Sharpe Ratio = -0.202
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OCUP |
Estimated Market Risk
| 4.14 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.84 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ocuphire Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ocuphire Pharma by adding Ocuphire Pharma to a well-diversified portfolio.
Price Book 0.9149 | Enterprise Value Ebitda (2.66) | Price Sales 2.3968 | Shares Float 23.8 M | Wall Street Target Price 19.2 |
Ocuphire Pharma Valuation on November 25, 2020
It is possible to determine the worth of Ocuphire Pharma on a given historical date. On November 25, 2020 Ocuphire was worth 2.91 at the beginning of the trading date compared to the closed value of 2.87. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ocuphire Pharma stock. Still, in general, we apply an absolute valuation method to find Ocuphire Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ocuphire Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ocuphire Pharma's related companies.
| Open | High | Low | Close | Volume | |
04/11/2022 | 2.91 | 2.91 | 2.80 | 2.87 | 152,620 |
| 2.85 | 2.87 | 2.70 | 2.82 | 312,335 |
| Backtest Ocuphire Pharma | | | Ocuphire Pharma History | | | Ocuphire Pharma Valuation | Next |
Ocuphire Pharma Trading Date Momentum on November 25, 2020
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Ocuphire Pharma Fundamentals Correlations and Trends
By evaluating Ocuphire Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ocuphire Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ocuphire financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ocuphire Pharma Stock history
Ocuphire Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ocuphire is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ocuphire Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ocuphire Pharma stock prices may prove useful in developing a viable investing in Ocuphire Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 21.6 M | 20.5 M | |
| Net Income Applicable To Common Shares | 16.1 M | 16.9 M |
Ocuphire Pharma Quarterly Net Working Capital |
|
Ocuphire Pharma Stock Technical Analysis
Ocuphire Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ocuphire Pharma Period Price Range
Low | April 11, 2022
| High |
2.91 | 2.87 |
Ocuphire Pharma April 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Ocuphire Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ocuphire Pharma shares will generate the highest return on investment. By undertsting and applying Ocuphire Pharma stock market strength indicators, traders can identify Ocuphire Pharma entry and exit signals to maximize returns
Ocuphire Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ocuphire Pharma's price direction in advance. Along with the technical and fundamental analysis of Ocuphire Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ocuphire to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.91) | |||
| Total Risk Alpha | (1.34) | |||
| Treynor Ratio | (0.57) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocuphire Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. To learn how to invest in Ocuphire Stock, please use our How to Invest in Ocuphire Pharma guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Ocuphire Stock analysis
When running Ocuphire Pharma's price analysis, check to measure Ocuphire Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocuphire Pharma is operating at the current time. Most of Ocuphire Pharma's value examination focuses on studying past and present price action to predict the probability of Ocuphire Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocuphire Pharma's price. Additionally, you may evaluate how the addition of Ocuphire Pharma to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Ocuphire Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocuphire Pharma. If investors know Ocuphire will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocuphire Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.882 | Quarterly Revenue Growth (0.96) | Return On Assets (0.13) | Return On Equity (0.21) |
The market value of Ocuphire Pharma is measured differently than its book value, which is the value of Ocuphire that is recorded on the company's balance sheet. Investors also form their own opinion of Ocuphire Pharma's value that differs from its market value or its book value, called intrinsic value, which is Ocuphire Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocuphire Pharma's market value can be influenced by many factors that don't directly affect Ocuphire Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocuphire Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocuphire Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocuphire Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.